Publication Author: Zeliadt_Steven

• Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis.

  Farias AJ, Hansen RN, Zeliadt SB, Ornelas IJ, Li CI, Thompson B. Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis. J Manag Care Spec Pharm. 2

  rakerr2

  August 1, 2016

• Appropriateness of Prostate Cancer Imaging among Veterans in a Delivery System without Incentives for Overutilization.

  Makarov DV, Hu EY, Walter D, Braithwaite RS, Sherman S, Gold HT, Zhou XH, Gross CP, Zeliadt SB. Appropriateness of Prostate Cancer Imaging among Veterans in a Delivery System without Incentives for Overutilization. Health Serv Res. 2016 Jun;51(3):1021-51.

  rakerr2

  June 1, 2016

• An assessment of data quality in a multi-site electronic medical record system in Haiti.

  Puttkammer N, Baseman JG, Devine EB, Valles JS, Hyppolite N, Garilus F, Honoré JG, Matheson AI, Zeliadt S, Yuhas K, Sherr K, Cadet JR, Zamor G, Pierre E, Barnhart S. An assessment of data quality in a multi-site electronic medical record system in Haiti.

  rakerr2

  February 1, 2016

• Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.

  Hoffman RM, Meisner AL, Arap W, Barry M, Shah SK, Zeliadt SB, Wiggins CL. Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):259-63. doi: 10.1158/1055-9965.EPI-15-0723. Epu

  rakerr2

  February 1, 2016

• Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer.

  Loggers ET, Buist DS, Gold LS, Zeliadt S, Hunter Merrill R, Etzioni R, Ramsey SD, Sullivan SD, Kessler L. Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer. Int J Breast Cancer. 2016;2016:2182985. doi: 10.11

  rakerr2

  January 1, 2016

• Imaging surveillance and survival for surgically resected non-small-cell lung cancer.

  Backhus LM, Farjah F, Liang CK, He H, Varghese TK Jr, Au DH, Flum DR, Zeliadt SB. Imaging surveillance and survival for surgically resected non-small-cell lung cancer. J Surg Res. 2016 Jan;200(1):171-6. doi: 10.1016/j.jss.2015.06.048. Epub 2015 Jun 25.

  rakerr2

  January 1, 2016

• Metformin effects on biochemical recurrence and metabolic signaling in the prostate.

  Winters B, Plymate S, Zeliadt SB, Holt S, Zhang X, Hu E, Lin DW, Morrissey C, Wooldridge B, Gore JL, Porter MP, Wright JL. Metformin effects on biochemical recurrence and metabolic signaling in the prostate. Prostate. 2015 Nov;75(15):1694-703. doi: 10.100

  rakerr2

  November 1, 2015

• Attitudes and Perceptions About Smoking Cessation in the Context of Lung Cancer Screening.

  Zeliadt SB, Heffner JL, Sayre G, Klein DE, Simons C, Williams J, Reinke LF, Au DH. Attitudes and Perceptions About Smoking Cessation in the Context of Lung Cancer Screening. JAMA Intern Med. 2015 Sep;175(9):1530-7. doi: 10.1001/jamainternmed.2015.3558.

  rakerr2

  September 1, 2015

• Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.

  Macleod LC, Chery LJ, Hu EY, Zeliadt SB, Holt SK, Lin DW, Porter MP, Gore JL, Wright JL. Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort. Prostate Cancer Prostatic Dis. 2015 Jun;18(2)

  rakerr2

  June 1, 2015

• Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans.

  Walsh TJ, Shores MM, Fox AE, Moore KP, Forsberg CW, Kinsey CE, Heckbert SR, Zeliadt S, Thompson ML, Smith NL, Matsumoto AM. Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans. Andrology. 2015 Mar;3(2)

  rakerr2

  March 1, 2015